Head of R&D (Antibody)

Company: GenScript
Location: Dayton
Posted on: January 16, 2022

Job Description:

Role Description:We are looking for vice president to lead the R&D team. This team will provide advanced technologies & methods to support the Biologics. You will establish and develop innovative technologies or approaches within antibody drug field, which will have a significant impact on the antibody drug business.Key Responsibilities:1. Develop and implement strategies and tactical plans to drive the improvement of R&D system. 2. Maintain current knowledge of emerging technologies in the antibody drug area and recognize opportunities to apply the knowledge to new products development.3. Develop project, resource and budget plans to support execution of the defined antibody drug R&D program deliverables.4. Lead collaborations with other cross-functional groups to support the development and commercial launch of new products. 5. Recruit, retain and develop talents, and provide leadership for a high performing team to meet our overall business objectives. 6. Perform other duties as assigned based on business needs. Qualifications:1. A Ph.D. degree in immunology, molecular biology, or other related biological science with proven experience in scientific achievements for more than 7 years, preferably in an industry setting is required.2. Expert knowledge and skills monoclonal antibody, recombinant proteins, and antibody conjugates is preferred, with demonstrated expertise in upstream and/or downstream process development and analytical expertise is a bonus.3. Strong leadership and communication skills and demonstrated experience in new techniques and products development. 4. Direct management experience with successful track record of building, coaching and mentoring a high-performing team.5. Strong interpersonal, verbal, and written communication skills.6. Bi-lingual, fluent in Chinese and English reading, writing and conversation.

Keywords: GenScript, Trenton , Head of R&D (Antibody), Other , Dayton, New Jersey